|
VRK1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.975200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.965050E-01 |
| Normal-vs-Stage2 |
6.989800E-01 |
| Normal-vs-Stage3 |
6.792600E-01 |
| Normal-vs-Stage4 |
3.255400E-01 |
| Stage1-vs-Stage2 |
7.053800E-01 |
| Stage1-vs-Stage3 |
1.520590E-01 |
| Stage1-vs-Stage4 |
8.742200E-01 |
| Stage2-vs-Stage3 |
5.121000E-01 |
| Stage2-vs-Stage4 |
7.163200E-01 |
| Stage3-vs-Stage4 |
3.227400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.574800E-01 |
| Normal-vs-AfricanAmerican |
7.000600E-01 |
| Normal-vs-Asian |
4.409800E-01 |
| Caucasian-vs-AfricanAmerican |
5.342600E-01 |
| Caucasian-vs-Asian |
3.176800E-01 |
| AfricanAmerican-vs-Asian |
4.168400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.778300E-02 |
| Normal-vs-Female |
9.639700E-02 |
| Male-vs-Female |
4.361900E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.690600E-01 |
| Normal-vs-Extreme_Weight |
8.243900E-02 |
| Normal-vs-Obese |
7.281000E-01 |
| Normal-vs-Extreme_Obese |
3.400000E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.480400E-01 |
| Normal_Weight-vs-Obese |
2.362000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.679000E-01 |
| Extreme_Weight-vs-Obese |
2.927900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.971000E-01 |
| Obese-vs-Extreme_Obese |
6.998200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.274500E-02 |
| Normal-vs-Age(41-60Yrs) |
9.799800E-01 |
| Normal-vs-Age(61-80Yrs) |
7.605700E-02 |
| Normal-vs-Age(81-100Yrs) |
1.723750E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.899600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.748070E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.880100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.679100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.284900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.537000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.760800E-01 |
| Normal-VS-Type2 PRCC |
6.676400E-03 |
| Normal-VS-KIRP CIMP |
3.415500E-02 |
| Normal-VS-Unclassified PRCC |
6.193400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.034420E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.984300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.571800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.399800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.788300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.520300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.898310E-02 |
| Normal-vs-N1 |
4.170200E-02 |
| Normal-vs-N2 |
1.059830E-01 |
| N0-vs-N1 |
1.599430E-03 |
| N0-vs-N2 |
5.503800E-01 |
| N1-vs-N2 |
8.638000E-02 |
|
|
